These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 27693004)

  • 1. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.
    Mulders TA; Sivapalaratnam S; Stroes ES; Kastelein JJ; Guerci AD; Pinto-Sietsma SJ
    JACC Cardiovasc Imaging; 2012 Mar; 5(3):252-60. PubMed ID: 22421169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Rhee EJ; Park SE; Oh HG; Park CY; Oh KW; Park SW; Blankstein R; Plutzky J; Lee WY
    Atherosclerosis; 2015 May; 240(1):242-9. PubMed ID: 25818250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.
    Mortensen MB; Falk E; Li D; Nasir K; Blaha MJ; Sandfort V; Rodriguez CJ; Ouyang P; Budoff M
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):221-230. PubMed ID: 28624395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV; Spahillari A; Mwasongwe S; Carr JJ; Terry JG; Mentz RJ; Addison D; Hoffmann U; Reis J; Freedman JE; Lima JAC; Correa A; Murthy VL
    JAMA Cardiol; 2017 Jun; 2(6):644-652. PubMed ID: 28315622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts.
    Akintoye E; Afonso L; Bengaluru Jayanna M; Bao W; Briasoulis A; Robinson J
    J Am Heart Assoc; 2021 Jun; 10(12):e019589. PubMed ID: 34092110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
    Mortensen MB; Fuster V; Muntendam P; Mehran R; Baber U; Sartori S; Falk E
    J Am Coll Cardiol; 2016 Aug; 68(9):881-91. PubMed ID: 27561760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins.
    Osawa K; Trejo MEP; Nakanishi R; McClelland RL; Blaha MJ; Blankstein R; McEvoy JW; Ceponiene I; Stein JH; Sacco RL; Polak JF; Budoff MJ
    Eur J Prev Cardiol; 2018 Dec; 25(18):1980-1987. PubMed ID: 30183342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of CAC Score and Risk of Incident CVD.
    Radford NB; DeFina LF; Barlow CE; Lakoski SG; Leonard D; Paixao AR; Khera A; Levine BD
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1420-1429. PubMed ID: 27372023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Coronary Artery Calcium Scoring for Statin Treatment Strategy according to ACC/AHA Guidelines in Asymptomatic Korean Adults.
    Han D; Ó Hartaigh B; Lee JH; Rizvi A; Park HE; Choi SY; Sung J; Chang HJ
    Yonsei Med J; 2017 Jan; 58(1):82-89. PubMed ID: 27873499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial.
    Muhlestein JB; Knowlton KU; Le VT; Lappe DL; May HT; Min DB; Johnson KM; Cripps ST; Schwab LH; Braun SB; Bair TL; Anderson JL
    JACC Cardiovasc Imaging; 2022 May; 15(5):843-855. PubMed ID: 34922872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Giugliano RP; Cannon CP; Blazing MA; Nicolau JC; Corbalán R; Špinar J; Park JG; White JA; Bohula EA; Braunwald E;
    Circulation; 2018 Apr; 137(15):1571-1582. PubMed ID: 29263150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed Tomography for Coronary Artery Calcification Scoring: Mammogram for the Heart.
    Qazi AH; Zallaghi F; Torres-Acosta N; Thompson RC; O'Keefe JH
    Prog Cardiovasc Dis; 2016; 58(5):529-36. PubMed ID: 26892393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Society of Australia and New Zealand position statement executive summary: coronary artery calcium scoring.
    Hamilton-Craig CR; Chow CK; Younger JF; Jelinek VM; Chan J; Liew GY
    Med J Aust; 2017 Oct; 207(8):357-361. PubMed ID: 29020908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine CAC-scoring prior to initiation of statin therapy - a European perspective.
    Mahabadi AA; Nasir K; Rassaf T
    Eur J Prev Cardiol; 2019 Sep; 26(14):1559-1561. PubMed ID: 30913900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.